Birchview Capital’s Verastem VSTM Stock Holding History

Birchview Capital’s Portfolio VSTM Stock Details VSTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-150,000	Closed	-$795K	–	86
2026 Q1	$795K	Hold	150,000	–	–	0.45%	47
2025 Q4	$1.16M	Buy	+150,000	New	+$1.34M	0.68%	36

Other funds holding VSTM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Birchview Capital's VSTM Position: Q2 2026 in Review

Birchview Capital sold out of Verastem (VSTM) in Q2 2026, closing a stake of 150,000 shares — an estimated $795K sold.

Birchview Capital first reported a position in VSTM in Q4 2025 and held it in 2 quarters. The position peaked at $1.16M in Q4 2025. 157 funds tracked by Wall St. Rank hold VSTM as of Q2 2026.

Birchview Capital reported no remaining Verastem position as of Q2 2026 after selling out during the quarter.
Birchview Capital sold 150,000 Verastem shares in Q2 2026, an estimated $795K.
Birchview Capital first reported a position in Verastem in Q4 2025 and held it in 2 quarters.
Birchview Capital's Verastem position peaked at $1.16M in Q4 2025.
157 funds tracked by Wall St. Rank held Verastem as of Q2 2026.

Based on Birchview Capital's 13F filing for Q2 2026, filed 14 Aug 2026.